NSG 6998 APEA PRE-PREDICTOR FINAL EXAM STUDY GUIDE
2026/2027 | COMPLETE QUESTIONS, CORRECT ANSWERS &
IN-DEPTH RATIONALES | SOUTH UNIVERSITY NURSING |
VERIFIED A+ SOLUTIONS
Q:
PRESCRIPTIVE AUTHORITY:
ANS:
MAY BE EXERCISED BY GIVING A VERBAL MEDICATION ORDER TO A PHARMACIST.
AN EXAMPLE OF EXERCISING PRESCRIPTIVE AUTHORITY IS GIVING A VERBAL
ORDER TO A PHARMACIST OR WRITING AN ORDER FOR A PRESCRIPTION
MEDICATION. PRESCRIPTIVE AUTHORITY RULES AND REGULATIONS VARY
FROM STATE TO STATE. PRESCRIPTIVE AUTHORITY IS GRANTED ONLY TO THOSE
APRNS WHO MEET THE REQUIREMENTS OF THE GOVERNING BODY FOR THE
STATE IN WHICH THE APRN PRACTICES.
Q:
WHEN EXAMINING A PREGNANT PATIENT, WHERE SHOULD THE FUNDAL HEIGHT BE
AT 22 WEEKS?
ANS:
ABOVE THE UMBILICUS
BETWEEN 18 AND 32 WEEKS, THERE IS GOOD CORRELATION BETWEEN FUNDAL
HEIGHT AND GESTATIONAL AGE OF THE FETUS. THE EXPECTED HEIGHTS ARE:
10-12 WEEKS: FUNDUS SLIGHTLY ABOVE THE SYMPHYSIS PUBIS 16 WEEKS:
FUNDUS MIDWAY BETWEEN THE SYMPHYSIS PUBIS AND UMBILICUS 20 WEEKS:
FUNDUS AT THE LEVEL OF UMBILICUS 28 WEEKS: FUNDUS 3 FINGERBREADTHS
ABOVE THE UMBILICUS 36 WEEKS: FUNDUS JUST BELOW THE XIPHOID PROCESS
Q:
, WHAT INTERVENTION DOES THE AMERICAN COLLEGE OF RHEUMATOLOGY
RECOMMEND AS FIRST-LINE THERAPY FOR OSTEOARTHRITIS?
ANS:
EXERCISE AND WEIGHT LOSS
EXERCISE, WEIGHT LOSS, AND REST ARE RECOMMENDED BY THE AMERICAN
COLLEGE OF RHEUMATOLOGY GUIDELINES FOR THE INITIAL MANAGEMENT OF
OSTEOARTHRITIS (OA). GIVEN THE ADVERSE EFFECTS OF MEDICATIONS USED
TO TREAT OA, IT IS BEST TO MINIMIZE DOSAGE AND DELAY USE AS LONG AS
POSSIBLE. AN EXTENSIVE DIAGNOSTIC WORKUP IS NOT RECOMMENDED UNLESS
THE PRESENTATION IS IN QUESTION. PATIENTS WHO HAVE SEVERE
DEGENERATIVE JOINT DISEASE (DJD), JOINT FUSION, OR WHOSE PAIN SEVERITY
IS NOT RELIEVED BY MORE CONSERVATIVE THERAPIES MAY BE CANDIDATES
FOR JOINT REPLACEMENT.
ACETAMINOPHEN IS RECOMMENDED AS A FIRST-LINE MEDICATION.
Q:
A 63-YEAR-OLD MALE RETIRED ACCOUNTANT COMPLAINS OF PAIN AND
STIFFNESS IN HIS FEET AND HANDS OF SEVERAL YEARS DURATION. HE REPORTS
THAT THE PAIN AND STIFFNESS BECOME WORSE WITH ACTIVITY. ON
EXAMINATION, HE IS NOTED TO HAVE HEBERDEN'S NODES BUT NO OTHER BONY
DEFORMITIES. WHICH OF THE FOLLOWING IS THE MOST PROBABLE DIAGNOSIS?
ANS:
OSTEOARTHRITIS (OA)
ALTHOUGH HIS VOCATION INVOLVED SEDENTARY ACTIVITY, THIS PATIENT IS
NOT AT GREAT RISK FOR OSTEOARTHRITIS. RHEUMATOID ARTHRITIS IS
CHARACTERIZED BY SEVERAL JOINT DEFORMITIES, USUALLY BILATERALLY
SYMMETRICAL. RA IS CHARACTERIZED BY INFLAMMATORY PROCESSES, WHILE
OA IS NOT. RA AND OA ARE CHRONIC CONDITIONS. GOUT IS CHARACTERIZED
BY ACUTE EXACERBATIONS RELATED TO A DEFECT IN PURINE METABOLISM,
INCREASED URIC ACID PRODUCTION, OR DECREASED URIC ACID EXCRETION.
Q:
2026/2027 | COMPLETE QUESTIONS, CORRECT ANSWERS &
IN-DEPTH RATIONALES | SOUTH UNIVERSITY NURSING |
VERIFIED A+ SOLUTIONS
Q:
PRESCRIPTIVE AUTHORITY:
ANS:
MAY BE EXERCISED BY GIVING A VERBAL MEDICATION ORDER TO A PHARMACIST.
AN EXAMPLE OF EXERCISING PRESCRIPTIVE AUTHORITY IS GIVING A VERBAL
ORDER TO A PHARMACIST OR WRITING AN ORDER FOR A PRESCRIPTION
MEDICATION. PRESCRIPTIVE AUTHORITY RULES AND REGULATIONS VARY
FROM STATE TO STATE. PRESCRIPTIVE AUTHORITY IS GRANTED ONLY TO THOSE
APRNS WHO MEET THE REQUIREMENTS OF THE GOVERNING BODY FOR THE
STATE IN WHICH THE APRN PRACTICES.
Q:
WHEN EXAMINING A PREGNANT PATIENT, WHERE SHOULD THE FUNDAL HEIGHT BE
AT 22 WEEKS?
ANS:
ABOVE THE UMBILICUS
BETWEEN 18 AND 32 WEEKS, THERE IS GOOD CORRELATION BETWEEN FUNDAL
HEIGHT AND GESTATIONAL AGE OF THE FETUS. THE EXPECTED HEIGHTS ARE:
10-12 WEEKS: FUNDUS SLIGHTLY ABOVE THE SYMPHYSIS PUBIS 16 WEEKS:
FUNDUS MIDWAY BETWEEN THE SYMPHYSIS PUBIS AND UMBILICUS 20 WEEKS:
FUNDUS AT THE LEVEL OF UMBILICUS 28 WEEKS: FUNDUS 3 FINGERBREADTHS
ABOVE THE UMBILICUS 36 WEEKS: FUNDUS JUST BELOW THE XIPHOID PROCESS
Q:
, WHAT INTERVENTION DOES THE AMERICAN COLLEGE OF RHEUMATOLOGY
RECOMMEND AS FIRST-LINE THERAPY FOR OSTEOARTHRITIS?
ANS:
EXERCISE AND WEIGHT LOSS
EXERCISE, WEIGHT LOSS, AND REST ARE RECOMMENDED BY THE AMERICAN
COLLEGE OF RHEUMATOLOGY GUIDELINES FOR THE INITIAL MANAGEMENT OF
OSTEOARTHRITIS (OA). GIVEN THE ADVERSE EFFECTS OF MEDICATIONS USED
TO TREAT OA, IT IS BEST TO MINIMIZE DOSAGE AND DELAY USE AS LONG AS
POSSIBLE. AN EXTENSIVE DIAGNOSTIC WORKUP IS NOT RECOMMENDED UNLESS
THE PRESENTATION IS IN QUESTION. PATIENTS WHO HAVE SEVERE
DEGENERATIVE JOINT DISEASE (DJD), JOINT FUSION, OR WHOSE PAIN SEVERITY
IS NOT RELIEVED BY MORE CONSERVATIVE THERAPIES MAY BE CANDIDATES
FOR JOINT REPLACEMENT.
ACETAMINOPHEN IS RECOMMENDED AS A FIRST-LINE MEDICATION.
Q:
A 63-YEAR-OLD MALE RETIRED ACCOUNTANT COMPLAINS OF PAIN AND
STIFFNESS IN HIS FEET AND HANDS OF SEVERAL YEARS DURATION. HE REPORTS
THAT THE PAIN AND STIFFNESS BECOME WORSE WITH ACTIVITY. ON
EXAMINATION, HE IS NOTED TO HAVE HEBERDEN'S NODES BUT NO OTHER BONY
DEFORMITIES. WHICH OF THE FOLLOWING IS THE MOST PROBABLE DIAGNOSIS?
ANS:
OSTEOARTHRITIS (OA)
ALTHOUGH HIS VOCATION INVOLVED SEDENTARY ACTIVITY, THIS PATIENT IS
NOT AT GREAT RISK FOR OSTEOARTHRITIS. RHEUMATOID ARTHRITIS IS
CHARACTERIZED BY SEVERAL JOINT DEFORMITIES, USUALLY BILATERALLY
SYMMETRICAL. RA IS CHARACTERIZED BY INFLAMMATORY PROCESSES, WHILE
OA IS NOT. RA AND OA ARE CHRONIC CONDITIONS. GOUT IS CHARACTERIZED
BY ACUTE EXACERBATIONS RELATED TO A DEFECT IN PURINE METABOLISM,
INCREASED URIC ACID PRODUCTION, OR DECREASED URIC ACID EXCRETION.
Q:
